Results 31 to 40 of about 202,515 (300)

Case Report: Reversal and subsequent return of optic disc cupping in a myocilin (MYOC) gene-associated severe Juvenile Open-Angle Glaucoma (JOAG) patient [version 1; peer review: 2 approved]

open access: yesF1000Research, 2022
To our knowledge, this case report describes the first instance of reversal of glaucomatous optic nerve cupping in a young adult with a rare form of juvenile open-angle glaucoma (JOAG) associated with a novel variant of the myocilin gene (MYOC).
Sanchay Gupta   +5 more
doaj   +1 more source

Glaucoma

open access: yesThe Lancet, 2017
Glaucoma is a heterogeneous group of diseases characterised by cupping of the optic nerve head and visual-field damage. It is the most frequent cause of irreversible blindness worldwide. Progression usually stops if the intraocular pressure is lowered by 30-50% from baseline.
Jonas, Jost B   +5 more
openaire   +4 more sources

Composite drainage in glaucoma surgery [PDF]

open access: yes, 2021
PURPOSE. To assess the hypotensive effectiveness, frequency and nature of intra- and postoperative complications in patients with various clinical manifestations of refractory glaucoma.MATERIALS AND METHODS.
N. A. Aldasheva   +4 more
core   +1 more source

Evaluation of corneal biomechanics and bleb assessment with trabeculectomy versus augmented by ologen in the treatment of open angle glaucoma [PDF]

open access: yesArcades of Medicine
A prospective comparative study between trabeculectomy with MMC versus trabeculectomy with Ologen for patients with open angle glaucoma one year follows up. Introduction: Recent studies reported that the use of a biodegradable collagen glycosamino-glycan
Mahmoud Gad   +3 more
doaj   +1 more source

Glaucoma and the Glaucoma Theories

open access: yesThe American Journal of the Medical Sciences, 1905
n ...
openaire   +2 more sources

Intraocular lens power calculations in eyes with pseudoexfoliation syndrome

open access: yesScientific Reports, 2021
To compare refractive outcomes after cataract surgery in pseudoexfoliation syndrome (PEX) and control eyes and to investigate the accuracy of 3 intraocular lens (IOL) calculation formulas in these eyes.
Aleksandra Wlaź   +3 more
doaj   +1 more source

Efficacy and safety of XEN 45 gel stent alone or in combination with phacoemulsification in advanced open angle glaucoma patients: 1-year retrospective study [PDF]

open access: yesInternational Journal of Ophthalmology, 2020
AIM: To assess the effectiveness of the XEN 45 gel stent, either alone or combined with cataract surgery, in advanced stage open angle glaucoma (OAG) patients.
Teresa Laborda-Guirao   +2 more
doaj   +1 more source

Long-Term Surgical Outcomes of Glaucoma Drainage Implants in Eyes with Preoperative Intraocular Pressure Less than 19 mmHg

open access: yesJournal of Ophthalmology
Background. This retrospective review reports on patients who underwent glaucoma drainage implant (GDI) surgery and had baseline intraocular pressure (IOP) of ≤18 mmHg with at least one year of follow-up. Methods.
Shahin Hallaj   +9 more
doaj   +1 more source

International Study of Childhood Glaucoma

open access: yes, 2020
To ascertain the types of childhood glaucoma managed at major international centers, current clinical practice, and intraocular pressure (IOP) control and visual acuity (VA) outcomes. Prospective, multicenter, consecutive case series.
International Study of Childhood Glaucoma – Childhood Glaucoma Research Network Study Group   +3 more
core   +1 more source

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy